Evidence map›Paper›PMID 41993314›Full record

ArticlebioRxiv : the preprint server for biology2026

RNA Folding Nearest Neighbor Parameters Including the Modification 1-Methyl-Pseudouridine.

Elzbieta Kierzek, Thandolwethu S Shabangu, Olivia M Hiltke, Megan Miaro, Sebastian Arteaga, Brent M Znosko, Elizabeth A Jolley, Philip C Bevilacqua, John SantaLucia, Holly A SantaLucia and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Elzbieta KierzekInstitute of Bioorganic Chemistry of the Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.
Thandolwethu S ShabanguDepartment of Biochemistry & Biophysics and Center for RNA Biology, University of Rochester Medical Center, Rochester, New York 14526, USA.
Olivia M HiltkeDepartment of Biochemistry & Biophysics and Center for RNA Biology, University of Rochester Medical Center, Rochester, New York 14526, USA.
Megan MiaroDepartment of Biochemistry & Biophysics and Center for RNA Biology, University of Rochester Medical Center, Rochester, New York 14526, USA.
Sebastian ArteagaDepartment of Chemistry, Saint Louis University, Saint Louis, Missouri 63103, USA.
Brent M ZnoskoDepartment of Chemistry, Saint Louis University, Saint Louis, Missouri 63103, USA.
Elizabeth A JolleyDepartment of Chemistry and Center for RNA Molecular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.
Philip C BevilacquaDepartment of Chemistry and Center for RNA Molecular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.
John SantaLuciaDNA Software, Plymouth, Michigan 48170, USA.
Holly A SantaLuciaDNA Software, Plymouth, Michigan 48170, USA.
Haining LinModerna, Inc., Cambridge, Massachusetts 02142, USA.
Mihir MetkarModerna, Inc., Cambridge, Massachusetts 02142, USA.
Sharon AviranBiomedical Engineering Department and Genome Center, University of California Davis, Davis, California 95616, USA.
Marta Soszyńska-JóźwiakInstitute of Bioorganic Chemistry of the Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.
Ryszard KierzekInstitute of Bioorganic Chemistry of the Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.
David H MathewsDepartment of Biochemistry & Biophysics and Center for RNA Biology, University of Rochester Medical Center, Rochester, New York 14526, USA.ORCID 0000-0002-2907-6557

Funding

RNA folding and catalysis at the interface of biophysics and genomicsR35GM127064 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI PHILIP C BEVILACQUA · 2018 to 2026
$3.4M
Training in Wellness and Resiliency at the University of Rochester Medical Center and College of Arts, Sciences & EngineeringT32GM135134 · NIGMS · UNIVERSITY OF ROCHESTER · PI Jeffrey J Hayes, Lynne E Maquat · 2020 to 2026
$2.9M
RNA Structure Modeling Using Physics and Sequence ComparisonR35GM145283 · NIGMS · UNIVERSITY OF ROCHESTER · PI DAVID H. MATHEWS · 2022 to 2026
$2.7M
Understanding the Thermodynamics and Structure of RNA Secondary Structure MotifsR15GM085699 · NIGMS · SAINT LOUIS UNIVERSITY · PI ZNOSKO, BRENT · 2009 to 2025
$2.0M
Prediction of nearest neighbor parameters for folding RNAs with modified nucleotidesR21GM148835 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI AVIRAN, SHARON · 2023 to 2024
$369k
NIGMS NIH HHS R15 GM085699NIGMS NIH HHS R21 GM148835NIGMS NIH HHS R35 GM127064NIGMS NIH HHS R35 GM145283NIGMS NIH HHS T32 GM135134
6 · The paper itself

Abstract

Nearest neighbor analysis is commonly used to estimate RNA folding stabilities. In this contribution, we report a set of RNA folding nearest neighbor parameters for estimating free energy change for RNA sequences including 1-methyl-pseudouridine. Development of mRNA vaccines has identified 1-methyl-pseudouridine as a key nucleobase modification for suppressing innate immune responses. However, the contributions of these modifications to RNA folding stability were unclear. Our new parameters provide helical terms for 1-methyl-pseudouridine-adenine and 1-methyl-pseudouridine-guanine base pairs. The parameters also estimate loop stabilities for loops with 1-methyl-pseudouridine or a combination of 1-methyl-pseudouridine and uridine. These parameters are derived using 208 optical melting experiments and tested against an additional 16 optical melting experiments. On average, we find that substitution of uridine with 1-methyl-pseudouridine stabilizes RNA folding, with the extent of stabilization depending on adjacent sequence. The estimation of tRNA folding ensembles for tRNA sequences with 1-methyl-pseudouridine was significantly improved using the new nearest neighbor parameters. The new nearest neighbor parameters are provided as part of the RNAstructure software package. With these parameters, the secondary structures of natural sequences with 1-methyl-pseudouridine and mRNA therapeutics fully substituted with 1-methyl-pseudouridine can be modeled.

Identifiers

PMID41993314
PMCPMC13081809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.